Showing results (621-630 of 772) with videos related to
Sort By:
Pageof 78
The Lancet. Respiratory Medicine|October 6, 2019
Effect of a fluid bolus on cardiovascular collapse among critically ill adults undergoing tracheal intubation (PrePARE): a randomised controlled trialDavid R Janz, Jonathan D Casey, Matthew W Semler, et al.The Journal of Molecular Diagnostics : JMD|August 28, 2021
PCR-Free Shallow Whole Genome Sequencing for Chromosomal Copy Number Detection from Plasma of Cancer Patients Is an Efficient Alternative to the Conventional PCR-Based ApproachJamie J Beagan, Esther E E Drees, Phylicia Stathi, et al.International Journal of Cancer|December 31, 2010
Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive womenRenée M Overmeer, Jacqueline A Louwers, Chris J L M Meijer, et al.Gynecologic Oncology|February 11, 2015
Follow-up of high-risk HPV positive women by combined cytology and bi-marker CADM1/MAL methylation analysis on cervical scrapesViola M J Verhoef, Folkert J van Kemenade, Lawrence Rozendaal, et al.Sensors (Basel, Switzerland)|April 3, 2021
A Miniature Bio-Photonics Companion Diagnostics Platform for Reliable Cancer Treatment Monitoring in Blood FluidsMarianneza Chatzipetrou, Lefteris Gounaridis, George Tsekenis, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 18, 2017
Evaluation of p16/Ki-67 dual-stained cytology as triage test for high-risk human papillomavirus-positive womenRenée Mf Ebisch, Judith van der Horst, Meyke Hermsen, et al.International Journal of Cancer|June 14, 2014
Comparative performance of novel self-sampling methods in detecting high-risk human papillomavirus in 30,130 women not attending cervical screeningRemko P Bosgraaf, Viola M J Verhoef, Leon F A G Massuger, et al.International Journal of Cancer|September 30, 2020
Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter studyJesper Bonde, Arno Floore, Ditte Ejegod, et al.Journal of Clinical Pathology|August 7, 2016
DNA hypermethylation analysis in sputum of asymptomatic subjects at risk for lung cancer participating in the NELSON trial: argument for maximum screening interval of 2 yearsA Jasmijn Hubers, Daniëlle A M Heideman, Sylvia Duin, et al.Cancer Discovery|February 19, 2014
Reduced NF1 expression confers resistance to EGFR inhibition in lung cancerElza C de Bruin, Catherine Cowell, Patricia H Warne, et al.Pageof 78